Liver cancer is the fourth most common cancer in China and the third most common cause of death from cancer in China in 2015 (1) . It is estimated that over 50% of new cases of liver cancer in the world occurred in China each year (2) . As the most common type of liver cancer, hepatocellular carcinoma (HCC) has a dismal prognosis because most patients (about two thirds) had lost the opportunity of surgical therapy when HCC was detected at advanced stage (3) . Surveillance at regular intervals and early diagnosis of HCC is crucial for improving the patients' survival.
Currently, early detection of HCC is primarily based on noninvasive imaging methods, such as ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) and expression patterns of serologic tumor markers such as alphafetoprotein (AFP) (4) . Guidelines from the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) recommend surveillance using ultrasound alone. Chinese Liver Cancer Diagnosis and Treatment Guidelines recommend ultrasound and serum AFP level as monitoring methods for surveilling high-risk groups. However, most HCC continues to be diagnosed beyond an early stage due to insufficient sensitivity and specificity of current surveillance tools, highlighting the need for more accurate biomarkers to improve early HCC detection.
Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3), the glycosylated isoform of AFP, has been suggested as a biomarker for HCC early detection given its higher specificity than AFP. Clinical studies revealed a specificity of 92% and a sensitivity of 37-49% of AFP-L3 for early stage HCC detection when used alone (5-7). Prothrombin induced by vitamin K absence II (PIVKA II), also known as des-γ-carboxy prothrombin (DCP), is an abnormal prothrombin protein that is generated as a result of an acquired defect in posttranslational carboxylation (8) . Several studies suggested that DCP had a high specificity of approx. 90% and a sensitivity of 56% for early stage HCC detection when used alone (6, 9) . Although AFP-L3 or PIVKA II appears to have insufficient sensitivity when used alone, it may have potential additive benefit to AFP which may cause false 
